Biomechanically Compatible,Minimally Invasive Technique for Recurrence Free Groin Hernia Repair

NCT ID: NCT04764760

Last Updated: 2021-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

486 participants

Study Classification

INTERVENTIONAL

Study Start Date

1987-01-31

Study Completion Date

2001-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

"A bio-mechanically compatible, minimally invasive technique for recurrence-free groin hernia repair by implantation of Tensiflex mesh prosthesis for the enhancement of the tissue tensile strength of the fascia transversalis."

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hernia recurrences post-repair remain a confounding problem. The prospective study described herein tested Cooper's paradigm, which holds that abdominal pressure exceeding abdominal wall resistance causes hernia, by incorporating the Tensiflex mesh prosthesis which is a modified version of mesh prosthesis of Stoppa technique in the surgical treatment of patients with hernia. The study was 2-phased: the first phase involved the pre-peritoneal implantation of a bi-layered mesh for anatomical replacement of the damaged fascia. The second phase involved the implantation of the bi-layered Tensiflex mesh prosthesis for definitive and seamless augmentation of tensile strength in the myopectineal orifice of Fruchaud.

Eighty-three percent of our patients consumed analgesics for 3 days (3% reported no pain on day 3); however, by day 5, 86% reported pain intensity scores lower than 5. The median number of lost workdays was 7. Most importantly, the primary endpoint of 100% recurrence-free outcomes was met, as were the secondary endpoints (minimal pain, morbidity, and loss of workdays).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

All patients with confirmed inguinal hernias of all types
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phase 1:Study role tissue tensile strength

The tensile strength of the orifice of Frauchad was augmented by implantation of a Accordion fold shaped prosthesis.

Group Type OTHER

Wing shaped Tensiflex prosthesis

Intervention Type DEVICE

Curative inguinal hernia repair techniqque

Phase 2:Curative implantation of a custom designed bio-mechanically compatible Tensiflex prosthesis

The wing shaped custom designed tensiflex prosthesis in the groin was impanted as a curative technique since it provided seamless augmenation of the tensile tissue strength.

Group Type OTHER

Wing shaped Tensiflex prosthesis

Intervention Type DEVICE

Curative inguinal hernia repair techniqque

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wing shaped Tensiflex prosthesis

Curative inguinal hernia repair techniqque

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients with confirmed groin hernia of both sexes.

Exclusion Criteria

* none
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Joseph Mercy Oakland Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Narendra Tyagi MD

Former Chairman of surgery St. Joseph Mercy Oakland Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Narendra Tyagi, MD FACS

Role: PRINCIPAL_INVESTIGATOR

St.Joseph Mercy Oakland Pontiac

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St.Joseph Mercy Oakland Pontiac

Pontiac, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

StJosephMOH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Antimicrobial Hernia Repair Device
NCT02730936 WITHDRAWN NA
Chronic Pain After Inguinal Hernia Repair
NCT00820131 COMPLETED PHASE4
Hernia Repair in Multiply Morbid Patients
NCT00930787 TERMINATED PHASE4